Cognia Licenses ITI Technology to Build Drug-Discovery Database | GenomeWeb
NEW YORK (GenomeWeb News) – ITI Life Sciences has licensed its data-mining technology to bioinformatics company Cognia to develop a drug-discovery database, the companies said today.
Cognia’s European branch, Cognia EU, worked with an ITI research program and with the University of Edinburgh’s School of Informatics to develop the technology, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.